Aytu BioScience offering 18.75M shares to raise $7.5M
ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on commercializing novel products in the field of urology, today announced it has priced an... Read More
Tuesday May 3, 2016
Aytu BioScience awarded Health Canada approval for its MiOXSYSâ„¢ system for male infertility
ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on global commercialization of novel products in the field of urology, announced it has... Read More
Wednesday April 6, 2016
Aytu Bioscience announces first sales for male infertility system
ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the first... Read More
Tuesday February 9, 2016
Aytu adds two founders to board of directors
ENGLEWOOD -- Aytu BioScience, Inc .(OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, announced Josh Disbrow , Aytu''s... Read More
Thursday January 28, 2016
- 1
- 2
IN Sponsors
Browse
Entrepreneurial by Nature
